3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Other hematologic neoplasm
218
Lymphoid
177
Myeloid
113
Plasma cell
75
Dermatologic
55
Classical hematology
35
Sarcoma
28
Genitourinary
13
Gynecologic
12
Breast
10
CNS
6
Head & Neck
5
Gastrointestinal
5
Thoracic
3
Other neoplasm
3
Tumor-Agnostic
2
Other solid neoplasm
1
Interventions
Everolimus
25
Magnetic Resonance Spectroscopy
13
pembrolizumab
12
pasireotide
12
Sunitinib
11
Octreotide
11
lanreotide
10
cabozantinib
10
lenvatinib
8
Sorafenib
8
Cisplatin
8
Temozolomide
7
Etoposide
7
Bevacizumab
7
pazopanib
6
Paclitaxel
6
Nivolumab
6
Doxorubicin
6
Carboplatin
6
Capecitabine
6
vandetanib
5
gallium Ga 68 dotatate
5
Specimen Handling
5
trametinib
4
lutetium Lu 177 dotatate
4
dabrafenib
4
Mitotane
4
Iodine-131
4
telotristat ethyl
3
surufatinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
fludarabine phosphate
×
Endocrine
×
Clear all
No trials found.